Cardiac contractility modulation and subcutaneous defibrillator (S-ICD): First experience with simultaneous implantation

Pacing Clin Electrophysiol. 2023 Dec;46(12):1595-1598. doi: 10.1111/pace.14695. Epub 2023 Apr 4.

Abstract

Backgrounds: Two technologies, cardiac contractility modulation (CCM) and subcutaneous implantable cardioverter-defibrillator (S-ICD), can be successfully combined and applied to patients with advanced heart failure (HF) with reduced left ventricular ejection fraction (LVEF).

Case report: We reported a case of a 51-year-old man with reduced ejection fraction (LVEF = 33%) and a narrow QRS complex who first underwent simultaneous implantation of CCM and S-ICD.

Conclusion: Our case report aimed to reveal that the simultaneous implantation of CCM and S-ICD could be successfully used in patients with advanced HF, which could significantly improve the clinical symptoms of such patients during one surgery.

Keywords: advanced heart failure; cardiac contractility modulation (CCM); simultaneous implantation; subcutaneous implantable cardioverter-defibrillator (S-ICD).

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Defibrillators
  • Defibrillators, Implantable*
  • Heart Failure*
  • Humans
  • Male
  • Middle Aged
  • Pacemaker, Artificial*
  • Stroke Volume
  • Treatment Outcome
  • Ventricular Dysfunction, Left*
  • Ventricular Function, Left